iBio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IBIO research report →
About the company
iBio, Inc. , a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two distinct segments: Biopharmaceuticals and Bioprocessing.
- CEO
- Martin Brenner
- IPO
- 2008
- Employees
- 16
- HQ
- Bryan, TX, US
Price Chart
- Market Cap
- $26.53M
- P/E
- -2.92
- P/S
- 88.42
- P/B
- 2.59
- EV/EBITDA
- 0.71
- Div Yield
- 0.00%
- Gross Margin
- -160.00%
- Op Margin
- -7985.33%
- Net Margin
- -9202.00%
- ROE
- -53.86%
- ROIC
- -30.00%
- Revenue
- $400.00K · 77.78%
- Net Income
- $-18,377,000 · 26.22%
- EPS
- $-1.75 · 73.08%
- Op Income
- $-18,602,000
- FCF YoY
- 18.35%
- 52W High
- $3.82
- 52W Low
- $0.56
- 50D MA
- $1.70
- 200D MA
- $1.76
- Beta
- 1.27
- Avg Volume
- 932.01K
Get TickerSpark's AI analysis on IBIO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | Stoner Elizabeth | other | 60,000 |
| May 7, 26 | Stoner Elizabeth | other | 0 |
| Mar 26, 26 | Banjak Marc | buy | 1,434 |
| Mar 26, 26 | Banjak Marc | buy | 12,500 |
| Mar 19, 26 | Duran Felipe | buy | 24,835 |
| Mar 19, 26 | Brenner Martin | buy | 12,336 |
| Jan 28, 26 | Banjak Marc | other | 146,000 |
| Jan 28, 26 | Duran Felipe | other | 179,000 |
| Jan 28, 26 | Brenner Martin | other | 479,000 |
| Nov 20, 25 | Schimmelpennink Evert B. | other | 13,500 |
Our IBIO coverage
Recent articles, reports, and earnings notes.
No research on IBIO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IBIO report →Similar companies
Peers in the same neighborhood.